1.Wang X, Guo Q, Wang H, et al. PCBP2 Posttranional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E. Mol Cancer Res. 2021;19(1):86-98
2. Wang X, Bi X, Huang X, Wang B, Guo Q, Wu Z. Systematic investigation of biomarker-[like] role of ARHGDIB in breast cancer. Cancer Biomark. 2020;28(1):101-110.
3. Huang X, Wang X, Yuan X, Wu W, Lobie PE, Wu Z, XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation. Oncogene, 2019;38(9): 1448-1460.
4. Ding K, Tan S, Huang X, Wang X, Li X, Fan R, Zhu Y, Lobie PE, Wang W, Wu Z, GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem, 2018;293(11): 3949-3964.
5. Wang X, Wang S, Pandey V, Chen P, Li Q, Wu Z, Wu Q, Lobie PE, Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma. Medicine (Baltimore), 2015;94(20): e860.
